| Helio Genomics’ HelioLiver Dx Test Meets Coprimary and Secondary Study Endpoints in the CLiMB Trial, Presented at the EASL Congress 2024 |
Globe Newswire |
06/10 |
16:00 |
| Precision Farming Market Opportunities and Leading Players 2024-2031 |
Globe Newswire |
06/10 |
16:00 |
| Clinical ink Appoints Dr. Nicholas Alp, MD PhD FACC as Chief Medical Officer |
Globe Newswire |
06/10 |
16:00 |
| Virtu Financial, Inc. Announces Proposed Opportunistic Private Offering of $500 Million of Senior First Lien Notes Due 2031 |
Globe Newswire |
06/10 |
15:39 |
| 6500% Growth in One Month - Talentir, the most anticipated Web3 creative project in 2024 |
Globe Newswire |
06/10 |
15:35 |
| BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression |
Globe Newswire |
06/10 |
15:30 |
| FuelCell Energy Reports Second Quarter of Fiscal 2024 Results |
Globe Newswire |
06/10 |
15:30 |
| Lilium launches China Legal Entity as part of collaboration with the Bao’an District of Shenzhen |
Globe Newswire |
06/10 |
15:30 |
| BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) |
Globe Newswire |
06/10 |
15:30 |
| American Oncology Network Announces the Commencement of OTCQX Trading |
Globe Newswire |
06/10 |
15:15 |
| Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program |
Globe Newswire |
06/10 |
15:00 |
| Nurix Therapeutics to Host a Webcast and Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of NX-5948 Being Presented at the European Hematology Association Congress (EHA2024) |
Globe Newswire |
06/10 |
15:00 |
| Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer |
Globe Newswire |
06/10 |
15:00 |
| Critical Metals Corp. to Acquire Tanbreez, One of the World’s Largest Known Rare Earths Assets |
Globe Newswire |
06/10 |
15:00 |
| PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial |
Globe Newswire |
06/10 |
15:00 |
| Eyeris Wins “Automotive Tech Company of the Year” and “Automotive Product of the Year” Awards at AutoTech: Detroit 2024 |
Globe Newswire |
06/10 |
15:00 |
| SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA) |
Globe Newswire |
06/10 |
15:00 |
| Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform |
Globe Newswire |
06/10 |
15:00 |
| Capstreet-backed PlanetBids Names Paul Colangelo and Max Schnoedl to its Board |
Globe Newswire |
06/10 |
15:00 |
| C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors |
Globe Newswire |
06/10 |
15:00 |
| Ocwen Financial Officially Rebrands as Onity™ Group |
Globe Newswire |
06/10 |
14:45 |
| ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates |
Globe Newswire |
06/10 |
14:30 |
| Chart Industries Joins the United Nations Global Compact |
Globe Newswire |
06/10 |
14:30 |
| Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer |
Globe Newswire |
06/10 |
14:00 |
| Comstock Expanding Partnership with RenFuel |
Globe Newswire |
06/10 |
14:00 |
